• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物系统中DNA胞嘧啶甲基化排泄的超高效液相色谱串联质谱分析

Ultraperformance Liquid Chromatography Tandem Mass Spectrometry Assay of DNA Cytosine Methylation Excretion from Biological Systems.

作者信息

Qu Jing, Kumar Avinash, Liu Yi-Ming, Odubanjo Oluwatoyin V, Noubissi Felicite K, Hu Yixin, Hu Hankun

机构信息

Jackson State University, Department of Chemistry, Physics and Atmospheric Science, Jackson, Mississippi 39217, United States.

Department of Biology, Jackson State University, Jackson, Mississippi 39217, United States.

出版信息

ACS Omega. 2025 Mar 25;10(13):13370-13376. doi: 10.1021/acsomega.4c11277. eCollection 2025 Apr 8.

DOI:10.1021/acsomega.4c11277
PMID:40224404
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11983177/
Abstract

Measuring DNA cytosine methylation excretion presents challenges because methylated cytosine species are released in various forms including free molecules and those bound in DNA fragments. Herein, we report a novel UPLC-MS/MS method that allows the quantification of both free and DNA fragment-bound forms of methylated cytosine species excreted, providing total amounts for each. Cell culture medium and genomic DNA isolated from cells are analyzed to quantify methylated cytosine species. In genomic DNA isolated from MDA-MB-231 breast cancer cells, 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) are detected at 5.1% and 0.07% of total cytosine residues, respectively. In the cell culture medium, only 5hmC is detected at a low level (ca. 7 nM). However, in two normal cell lines (i.e., primary mouse lung epithelial cells and HEK293 kidney cells) 5mC, 5-methylcytidine, and 2'-oxymethylcytidine (but no 5hmC) are found present in cell culture medium at concentrations ranging from 10 to 320 nM. Further, it is observed for the first time that treating MDA-MB-231 cells with carboplatin significantly increases the 5hmC level in the culture medium, indicating a carboplatin-boosted DNA cytosine methylation excretion from cancer cells.

摘要

测量DNA胞嘧啶甲基化排泄存在挑战,因为甲基化胞嘧啶物种以多种形式释放,包括游离分子和与DNA片段结合的分子。在此,我们报告了一种新颖的超高效液相色谱-串联质谱法,该方法能够对排泄的甲基化胞嘧啶物种的游离形式和与DNA片段结合的形式进行定量,从而提供每种形式的总量。对细胞培养基和从细胞中分离的基因组DNA进行分析,以定量甲基化胞嘧啶物种。在从MDA-MB-231乳腺癌细胞中分离的基因组DNA中,5-甲基胞嘧啶(5mC)和5-羟甲基胞嘧啶(5hmC)分别占总胞嘧啶残基的5.1%和0.07%。在细胞培养基中,仅检测到低水平(约7 nM)的5hmC。然而,在两种正常细胞系(即原代小鼠肺上皮细胞和HEK293肾细胞)的细胞培养基中发现存在浓度范围为10至320 nM的5mC、5-甲基胞苷和2'-氧甲基胞苷(但未检测到5hmC)。此外,首次观察到用卡铂处理MDA-MB-231细胞会显著提高培养基中的5hmC水平,表明卡铂促进了癌细胞的DNA胞嘧啶甲基化排泄。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c26f/11983177/30fccf544450/ao4c11277_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c26f/11983177/3f762fc89d27/ao4c11277_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c26f/11983177/38835ba91afb/ao4c11277_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c26f/11983177/1b6cddafa094/ao4c11277_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c26f/11983177/30fccf544450/ao4c11277_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c26f/11983177/3f762fc89d27/ao4c11277_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c26f/11983177/38835ba91afb/ao4c11277_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c26f/11983177/1b6cddafa094/ao4c11277_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c26f/11983177/30fccf544450/ao4c11277_0004.jpg

相似文献

1
Ultraperformance Liquid Chromatography Tandem Mass Spectrometry Assay of DNA Cytosine Methylation Excretion from Biological Systems.生物系统中DNA胞嘧啶甲基化排泄的超高效液相色谱串联质谱分析
ACS Omega. 2025 Mar 25;10(13):13370-13376. doi: 10.1021/acsomega.4c11277. eCollection 2025 Apr 8.
2
Quantification of Global DNA Methylation Levels by Mass Spectrometry.通过质谱法对全球DNA甲基化水平进行定量分析。
Methods Mol Biol. 2018;1708:49-58. doi: 10.1007/978-1-4939-7481-8_3.
3
A validated quantitative liquid chromatography-tandem quadrupole mass spectrometry method for monitoring isotopologues to evaluate global modified cytosine ratios in genomic DNA.一种经过验证的定量液相色谱-串联四极杆质谱法,用于监测同位素异构体以评估基因组DNA中的整体修饰胞嘧啶比率。
J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Mar 15;953-954:38-47. doi: 10.1016/j.jchromb.2014.01.050. Epub 2014 Feb 7.
4
Detection of human urinary 5-hydroxymethylcytosine by stable isotope dilution HPLC-MS/MS analysis.采用稳定同位素稀释 HPLC-MS/MS 分析检测人尿 5-羟甲基胞嘧啶。
Anal Chem. 2015 Feb 3;87(3):1846-52. doi: 10.1021/ac5038895. Epub 2015 Jan 14.
5
Simultaneous determination of global DNA methylation and hydroxymethylation levels by hydrophilic interaction liquid chromatography-tandem mass spectrometry.采用亲水作用液相色谱-串联质谱法同时测定整体DNA甲基化和羟甲基化水平。
J Biomol Screen. 2012 Aug;17(7):877-84. doi: 10.1177/1087057112447946. Epub 2012 May 29.
6
Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine.检测 DNA 甲基化分析技术针对 5-甲基胞嘧啶和 5-羟甲基胞嘧啶的特异性。
Nucleic Acids Res. 2010 Jun;38(11):e125. doi: 10.1093/nar/gkq223. Epub 2010 Apr 5.
7
Demethylation Status of Somatic DNA Extracted From Pituitary Neuroendocrine Tumors Indicates Proliferative Behavior.从垂体神经内分泌肿瘤中提取的体细胞 DNA 的去甲基化状态表明其增殖行为。
J Clin Endocrinol Metab. 2020 Jun 1;105(6). doi: 10.1210/clinem/dgaa156.
8
Quantitative analysis of global 5-methyl- and 5-hydroxymethylcytosine in TET1 expressed HEK293T cells.TET1表达的HEK293T细胞中全球5-甲基胞嘧啶和5-羟甲基胞嘧啶的定量分析。
Biosens Bioelectron. 2020 Nov 1;167:112472. doi: 10.1016/j.bios.2020.112472. Epub 2020 Jul 28.
9
Global DNA 5-hydroxymethylcytosine level and its chromosomal distribution in four rye species.四个黑麦物种中全球 DNA 5-羟甲基胞嘧啶水平及其染色体分布。
J Exp Bot. 2023 Jun 27;74(12):3488-3502. doi: 10.1093/jxb/erad102.
10
Lead exposure induces changes in 5-hydroxymethylcytosine clusters in CpG islands in human embryonic stem cells and umbilical cord blood.铅暴露会诱导人类胚胎干细胞和脐带血中CpG岛的5-羟甲基胞嘧啶簇发生变化。
Epigenetics. 2015;10(7):607-21. doi: 10.1080/15592294.2015.1050172.

本文引用的文献

1
Differential methylation of circulating free DNA assessed through cfMeDiP as a new tool for breast cancer diagnosis and detection of BRCA1/2 mutation.通过 cfMeDiP 评估循环游离 DNA 的甲基化差异作为乳腺癌诊断和检测 BRCA1/2 突变的新工具。
J Transl Med. 2024 Oct 15;22(1):938. doi: 10.1186/s12967-024-05734-2.
2
Accurate Quantification of Ten Methylated Purine Nucleosides by Highly Sensitive and Stable Isotope-Diluted UHPLC-MS/MS.高灵敏度、稳定同位素稀释 UHPLC-MS/MS 法准确定量十种甲基化嘌呤核苷。
Anal Chem. 2024 Jul 16;96(28):11366-11373. doi: 10.1021/acs.analchem.4c01446. Epub 2024 Jul 6.
3
DNA methylation and its potential roles in common oral diseases.
DNA 甲基化及其在常见口腔疾病中的潜在作用。
Life Sci. 2024 Aug 15;351:122795. doi: 10.1016/j.lfs.2024.122795. Epub 2024 Jun 8.
4
An on-line SPE-LC-MS/MS method for quantification of nucleobases and nucleosides present in biological fluids.一种用于定量检测生物体液中碱基和核苷的在线 SPE-LC-MS/MS 方法。
Anal Methods. 2024 Apr 25;16(16):2505-2512. doi: 10.1039/d4ay00100a.
5
Periodic magnetic modulation enhanced electrochemical analysis for highly sensitive determination of genomic DNA methylation.周期性磁调制增强电化学分析用于高灵敏度测定基因组DNA甲基化。
Anal Biochem. 2024 Jul;690:115509. doi: 10.1016/j.ab.2024.115509. Epub 2024 Mar 19.
6
Quantification of modified nucleotides and nucleosides by isotope dilution mass spectrometry.利用同位素稀释质谱法对修饰核苷酸和核苷进行定量。
Mass Spectrom Rev. 2024 Sep-Oct;43(5):998-1018. doi: 10.1002/mas.21865. Epub 2023 Aug 19.
7
Circular and Circulating DNA in Inflammatory Bowel Disease: From Pathogenesis to Potential Molecular Therapies.炎症性肠病中的环状和循环DNA:从发病机制到潜在的分子疗法
Cells. 2023 Jul 27;12(15):1953. doi: 10.3390/cells12151953.
8
Multiplexed LC-MS/MS quantification of salivary RNA modifications in periodontitis.多重 LC-MS/MS 定量检测牙周炎患者唾液中的 RNA 修饰物。
J Periodontal Res. 2023 Oct;58(5):959-967. doi: 10.1111/jre.13155. Epub 2023 Jun 22.
9
Targeted DNA Demethylation: Vectors, Effectors and Perspectives.靶向DNA去甲基化:载体、效应物与展望
Biomedicines. 2023 Apr 30;11(5):1334. doi: 10.3390/biomedicines11051334.
10
DNA methylation and cancer: transcriptional regulation, prognostic, and therapeutic perspective.DNA甲基化与癌症:转录调控、预后及治疗前景
Med Oncol. 2023 Jan 5;40(2):71. doi: 10.1007/s12032-022-01943-1.